Latest Articles
Robotic Laparoscopy Beneficial in Endometrial Cancer - Physician's Weekly
Robotic Laparoscopy Beneficial in Endometrial Cancer Physician's Weekly
Published: April 29, 2025, 8:46 p.m.
Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis - Frontiers
Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis Frontiers
Published: April 28, 2025, 2:35 p.m.
Exploring the Future of Endometrial Cancer Treatment Market - openPR.com
Exploring the Future of Endometrial Cancer Treatment Market openPR.com
Published: April 28, 2025, 10:39 a.m.
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial - marketscreener.com
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial marketscreener.com
Published: April 28, 2025, 9:23 a.m.
Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study - Medical Dialogues
Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study Medical Dialogues
Published: April 25, 2025, 3 p.m.
Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data - Frontiers
Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data Frontiers
Published: April 25, 2025, 10:08 a.m.
AI diagnoses endometrial cancer with high accuracy - Lab + Life Scientist
AI diagnoses endometrial cancer with high accuracy Lab + Life Scientist
Published: April 23, 2025, 1:24 a.m.
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive
Published: April 21, 2025, 1:17 p.m.
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer Oncology Nurse Advisor
Published: April 21, 2025, 4 a.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive
Published: April 18, 2025, 3:54 p.m.
Link copied to clipboard!